Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
AMI Lifesciences is Driven by Chemistry. Powered by People.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Fursultiamine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fursultiamine, including repackagers and relabelers. The FDA regulates Fursultiamine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fursultiamine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Fursultiamine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Fursultiamine supplier is an individual or a company that provides Fursultiamine active pharmaceutical ingredient (API) or Fursultiamine finished formulations upon request. The Fursultiamine suppliers may include Fursultiamine API manufacturers, exporters, distributors and traders.
click here to find a list of Fursultiamine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Fursultiamine Drug Master File in Japan (Fursultiamine JDMF) empowers Fursultiamine API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Fursultiamine JDMF during the approval evaluation for pharmaceutical products. At the time of Fursultiamine JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Fursultiamine suppliers with JDMF on PharmaCompass.
Fursultiamine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fursultiamine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fursultiamine GMP manufacturer or Fursultiamine GMP API supplier for your needs.
A Fursultiamine CoA (Certificate of Analysis) is a formal document that attests to Fursultiamine's compliance with Fursultiamine specifications and serves as a tool for batch-level quality control.
Fursultiamine CoA mostly includes findings from lab analyses of a specific batch. For each Fursultiamine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fursultiamine may be tested according to a variety of international standards, such as European Pharmacopoeia (Fursultiamine EP), Fursultiamine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fursultiamine USP).
LOOKING FOR A SUPPLIER?
